BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lyu M, Fan G, Xiao G, Wang T, Xu D, Gao J, Ge S, Li Q, Ma Y, Zhang H, Wang J, Cui Y, Zhang J, Zhu Y, Zhang B. Traditional Chinese medicine in COVID-19. Acta Pharm Sin B 2021;11:3337-63. [PMID: 34567957 DOI: 10.1016/j.apsb.2021.09.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Tian H, He B, Yin Y, Liu L, Shi J, Hu L, Jiang G. Chemical Nature of Metals and Metal-Based Materials in Inactivation of Viruses. Nanomaterials (Basel) 2022;12:2345. [PMID: 35889570 DOI: 10.3390/nano12142345] [Reference Citation Analysis]
2 Jiang Y, Zhao T, Zhou X, Xiang Y, Gutierrez‐castrellon P, Ma X. Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions. MedComm 2022;3. [DOI: 10.1002/mco2.154] [Reference Citation Analysis]
3 Joli J, Buck P, Zipfel S, Stengel A. Post-COVID-19 fatigue: A systematic review. Front Psychiatry 2022;13:947973. [DOI: 10.3389/fpsyt.2022.947973] [Reference Citation Analysis]
4 Ruchawapol C, Fu WW, Xu HX. A review on computational approaches that support the researches on traditional Chinese medicines (TCM) against COVID-19. Phytomedicine 2022;104:154324. [PMID: 35841663 DOI: 10.1016/j.phymed.2022.154324] [Reference Citation Analysis]
5 Lu J, Lu W, Jiang H, Yang C, Dong X. Molecular Docking and Dynamics of Phytochemicals From Chinese Herbs With SARS-CoV-2 RdRp. Natural Product Communications 2022;17:1934578X2211056. [DOI: 10.1177/1934578x221105693] [Reference Citation Analysis]
6 Agrawal PK, Agrawal C, Blunden G. Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment? Molecules 2022;27:3828. [PMID: 35744958 DOI: 10.3390/molecules27123828] [Reference Citation Analysis]
7 Luo W, Ding R, Guo X, Zhan T, Tang T, Fan R, Wang Y. Clinical data mining reveals Gancao-Banxia as a potential herbal pair against moderate COVID-19 by dual binding to IL-6/STAT3. Comput Biol Med 2022;145:105457. [PMID: 35366469 DOI: 10.1016/j.compbiomed.2022.105457] [Reference Citation Analysis]
8 Loc HN, Lan TTN, Huong DTL, Tuyen NT, Quang TM, Dao LM, Van PH, Vuong NL. Traditional Vietnamese medicine Kovir capsule in patients with mild COVID-19: A double-blind randomized controlled trial. Phytother Res 2022. [PMID: 35695687 DOI: 10.1002/ptr.7455] [Reference Citation Analysis]
9 Hu Q, Xiong Y, Zhu GH, Zhang YN, Zhang YW, Huang P, Ge GB. The SARS-CoV-2 main protease (Mpro): Structure, function, and emerging therapies for COVID-19. MedComm (2020) 2022;3:e151. [PMID: 35845352 DOI: 10.1002/mco2.151] [Reference Citation Analysis]
10 Li M, Zhu H, Liu Y, Lu Y, Sun M, Zhang Y, Shi J, Shi N, Li L, Yang K, Sun X, Liu J, Ge L, Huang L. Role of Traditional Chinese Medicine in Treating Severe or Critical COVID-19: A Systematic Review of Randomized Controlled Trials and Observational Studies. Front Pharmacol 2022;13:926189. [DOI: 10.3389/fphar.2022.926189] [Reference Citation Analysis]
11 Yang C, Li D, Teng D, Zhou Y, Zhang L, Zhong Z, Yang G. Epigenetic Regulation in the Pathogenesis of Rheumatoid Arthritis. Front Immunol 2022;13:859400. [DOI: 10.3389/fimmu.2022.859400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Farmanpour-Kalalagh K, Beyraghdar Kashkooli A, Babaei A, Rezaei A, van der Krol AR. Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand. Front Plant Sci 2022;13:780257. [PMID: 35197994 DOI: 10.3389/fpls.2022.780257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Pang W, Yang F, Zhao Y, Dai E, Feng J, Huang Y, Guo Y, Zhou S, Huang M, Zheng W, Ma J, Li H, Li Q, Hou L, Zhang S, Wang H, Liu Q, Zhang B, Zhang J. Qingjin Yiqi granules for post-COVID-19 condition: A randomized clinical trial. J Evid Based Med 2022;15:30-8. [PMID: 35416437 DOI: 10.1111/jebm.12465] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wang D, Wang F, Kong X, Li Q, Shi H, Zhao S, Li W, Li Y, Meng J. The role of metabolic reprogramming in cancer metastasis and potential mechanism of traditional Chinese medicine intervention. Biomedicine & Pharmacotherapy 2022;153:113376. [DOI: 10.1016/j.biopha.2022.113376] [Reference Citation Analysis]